Cargando…

Innovative drug development for headache disorders /

Migraine treatment improved considerably with the advent of the 'triptans' in the 1990s. While the drugs used previously for headache treatment had efficacy, some compounds had bothersome side effects and their overuse could lead to severe complications. In the early days of the triptans,...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Olesen, Jes, Ramadan, Nabih
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Oxford ; New York : Oxford University Press, 2008.
Colección:Frontiers in headache research ; v. 16.
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Effectiveness of different steroid dosage in Tolosa-Hunt syndrome with different phenotypes: some critical points about the new International Headache Society classification / E. Marchioni [and others]
  • Discussion summary: trial methodology / Jes Olesen
  • Inducible nitric oxide synthase and development of new migraine treatments / Boris A. Chizh
  • Mechanisms of cortical spreading depression as targets for migraine therapy / Kevin C. Brennan and Andrew C. Charles
  • Tonabersat / Peter R. Blower and Paul C. Sharpe
  • Discussion summary: nitric oxide and spreading depression modulators / Nabih Ramadan
  • Calcitonin gene-related peptide: relevance for migraine / Jes Olesen and Inger Jansen-Olesen.
  • KATP channels and migraine / Inger Jansen-Olesen and Kenneth Beri Ploug
  • Antiepileptic drugs and migraine / Michael A. Rogawski
  • Discussion summary : ion channel modulators and antiepileptics / Pramod R. Saxena
  • Innovative drug development for headache disorders : glutamate / Kirk W. Johnson [and others]
  • The modulation of TRPV1 channels by cannabinoid1 receptors / Beatriz Fioravanti and Todd W. Vanderah
  • Future targets for headache therapy: prostanoids / Christian Waeber
  • Role of anandamide in the modulation of nitroglycerin-induced hyperalgesia: a study in the rat / Cristina Tassorelli [and others].